LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Orchard Therapeutics - U.S. and Millions of Other Companies

Sign up for full access to Orchard Therapeutics - U.S. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Recent Partnerships Orchard Therapeutics has established recent partnerships with companies like Er-Kim and Beneluxa, indicating collaboration opportunities for referring eligible patients and facilitating reimbursed access to their treatments.

Acquisition by Kyowa Kirin Acquisition by Kyowa Kirin presents synergistic possibilities for distributing Orchard Therapeutics' gene therapy products in new markets and leveraging Kyowa Kirin's global specialty pharmaceutical network for enhanced sales.

Fast Track Designation The FDA Fast Track designation for Orchard Therapeutics' OTL-203 in MPS-IH signifies accelerated development and potential earlier market entry, creating a competitive edge for sales outreach to healthcare providers and patients.

Revenue and Funding With a revenue range of $10M - 50M and substantial funding of $461M, Orchard Therapeutics has the financial stability to support sales expansion strategies, including product development, marketing efforts, and market penetration.

Competitive Landscape Orchard Therapeutics exists in a landscape of similar biotechnology companies like CRISPR Therapeutics, Sarepta Therapeutics, and uniQure, providing comparative insights to target specific customer segments and differentiate offerings.

Similar companies to Orchard Therapeutics - U.S.

✕

Access Insights for Orchard Therapeutics - U.S. and Millions of Other Companies

Sign up for full access to Orchard Therapeutics - U.S. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Orchard Therapeutics - U.S. Tech Stack

Orchard Therapeutics - U.S. uses 8 technology products and services including Cloudflare, WordPress, Shopify, and more. Explore Orchard Therapeutics - U.S.'s tech stack below.

  • Cloudflare
    Content Management System
  • WordPress
    Content Management System
  • Shopify
    E-commerce
  • Underscore.js
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Module Federation
    Miscellaneous
  • Amazon Web Services
    Platform As A Service
  • Adobe Tag Manager
    Tag Management

Media & News

Orchard Therapeutics - U.S.'s Email Address Formats

Orchard Therapeutics - U.S. uses at least 1 format(s):
Orchard Therapeutics - U.S. Email FormatsExamplePercentage
First.Last@orchard-tx.comJohn.Doe@orchard-tx.com
94%
Last_First@orchard-tx.comDoe_John@orchard-tx.com
3%
LastF@orchard-tx.comDoeJ@orchard-tx.com
1%
Last.F@orchard-tx.comDoe.J@orchard-tx.com
2%

Frequently Asked Questions

Where is Orchard Therapeutics - U.S.'s headquarters located?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S.'s main headquarters is located at 245 Hammersmith Road 3rd Floor London, United Kingdom W6 8PW GB. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Orchard Therapeutics - U.S.'s phone number?

Minus sign iconPlus sign icon You can contact Orchard Therapeutics - U.S.'s main corporate office by phone at
✕

Access Insights for Orchard Therapeutics - U.S. and Millions of Other Companies

Sign up for full access to Orchard Therapeutics - U.S. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-650-353-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orchard Therapeutics - U.S.'s stock symbol?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S. is a publicly traded company; the company's stock symbol is ORTX.

What is Orchard Therapeutics - U.S.'s official website and social media links?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S.'s official website is orchard-tx.com and has social profiles on LinkedIn.

How much revenue does Orchard Therapeutics - U.S. generate?

Minus sign iconPlus sign icon As of September 2024, Orchard Therapeutics - U.S.'s annual revenue reached $35M.

What is Orchard Therapeutics - U.S.'s SIC code NAICS code?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Orchard Therapeutics - U.S. have currently?

Minus sign iconPlus sign iconAs of September 2024, Orchard Therapeutics - U.S. has approximately 214 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: B. G.Chief Medical Officer: L. M.Chief Technical Officer: N. L.. Explore Orchard Therapeutics - U.S.'s employee directory with LeadIQ.

What industry does Orchard Therapeutics - U.S. belong to?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S. operates in the Biotechnology Research industry.

What technology does Orchard Therapeutics - U.S. use?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S.'s tech stack includes CloudflareWordPressShopifyUnderscore.jsOpen GraphModule FederationAmazon Web ServicesAdobe Tag Manager.

What is Orchard Therapeutics - U.S.'s email format?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S.'s email format typically follows the pattern of . Find more Orchard Therapeutics - U.S. email formats with LeadIQ.

How much funding has Orchard Therapeutics - U.S. raised to date?

Minus sign iconPlus sign icon As of September 2024, Orchard Therapeutics - U.S. has raised $461M in funding. The last funding round occurred on Aug 13, 2018 for $150M.

When was Orchard Therapeutics - U.S. founded?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S. was founded in 2015.
Orchard Therapeutics - U.S.

Orchard Therapeutics - U.S.

Biotechnology ResearchUnited Kingdom, United Kingdom201-500 Employees

Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease with a single treatment.

Founded in 2015, Orchard’s roots go back to some of the first research and clinical developments involving HSC gene therapy. Our team has played a central role in the evolution of this technology from a promising scientific idea to a potentially life-transforming reality. Today, Orchard is advancing a pipeline of HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist.

For more information, please visit www.orchard-tx.com.

✕

Access Insights for Orchard Therapeutics - U.S. and Millions of Other Companies

Sign up for full access to Orchard Therapeutics - U.S. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
245 Hammersmith Road 3rd Floor London, United Kingdom W6 8PW GB
Phone number
✕

Access Insights for Orchard Therapeutics - U.S. and Millions of Other Companies

Sign up for full access to Orchard Therapeutics - U.S. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-650-353-****
Website
orchard-tx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ORTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $461M

    Orchard Therapeutics - U.S. has raised a total of $461M of funding over 4 rounds. Their latest funding round was raised on Aug 13, 2018 in the amount of $150Mas a Series C.

  • $10M$50M

    Orchard Therapeutics - U.S.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $461M

    Orchard Therapeutics - U.S. has raised a total of $461M of funding over 4 rounds. Their latest funding round was raised on Aug 13, 2018 in the amount of $150Mas a Series C.

  • $10M$50M

    Orchard Therapeutics - U.S.'s revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Orchard Therapeutics - U.S. and Millions of Other Companies

Sign up for full access to Orchard Therapeutics - U.S. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.